Quantification of cerebrospinal fluid ferritin as a biomarker for CNS malignant infiltration

Arquivos de Neuro-Psiquiatria

Volumn 66, Issue 3 B, 2008, Pages 720-724

  De Almeida, Sérgio Monteiro ^a   Da Cunha, Dione Sosnitzki ^a   Yamada, Edna ^a   Doi, Elvira Missako ^a   Ono, Margaret ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Bacterial meningitis; Central nervous system; Cerebrospinal fluid; CNS neoplasm; CNS tumors; Ferritin; Malignant cells

Indexed keywords

BIOLOGICAL MARKER; FERRITIN;

ARTICLE; BACTERIAL MENINGITIS; CANCER CELL; CANCER DIAGNOSIS; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID CYTOLOGY; EARLY DIAGNOSIS; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MICROPARTICLE ENZYME IMMUNOASSAY; NEUROCYSTICERCOSIS; NEUROLOGIC DISEASE; PROTEIN CEREBROSPINAL FLUID LEVEL;

EID: 56049094382     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2008000500022     Document Type: Article

References (29)

1. Almeida SM, Nakanishi E, Conto AJ, et al. Cerebrospinal fluid cytological and biochemical characteristics in the presence of CNS neoplasia. Arq Neuropsiquiatr 2007;65:803-809.
2. Van Oostenbrugge RJ, Twijnstra A. Presenting features and value of diagnostic procedures in leptomeningeal metastases. Neurology 1999; 53:382-385.
3. Matzner Y, Konijn AM, Hershko C. Serum ferritin in hematological malignancies. Am J Hematol 1980;9:13-22.
4. Patel R, Shah PC, Vohra RM, et al. Serum ferritin levels in hematological malignant neoplasm. Arch Pathol Lab Med 1980;104:509-512.
5. Aulbert E, Schimidt CG. Ferritin: a tumor marker in myeloid leukemia. Cancer Detect Prev 1985;8:297-302.
6. Dormer MH, Abel U, Fritze D, et al. Serum ferritin in relation to the course of Hodgkin's disease. Cancer 1993;529:2308-2312.
7. Dillmann E, López-Karpovitch X, Alvarez-Hernández X, et al. Ferritin and malignant hemopathies: I. Ferritin in cerebrospinal fluid as an indicator of central nervous system leukemic involvement. Rev Invest Clin 1982;34:95-98.
8. Vicente V, Gonzalez M, Lopez-Borrasca A. Cerebrospinal fluid levels beta02 microglobulin and ferritin in lymphoproliferative disorders. Acta Paediatr Scand 1982;71:325-326.
9. Zandman-Goddard G, Matzner Y, Konijn AM, et al. Cerebrospinal fluid ferritin in malignant CNS involvement. Cancer 1986;58:1346-1349.
10. Sindic CJ, Collet-Cassart D, Cambiaso CL, et al. The clinical relevance of ferritin concentration in the cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1981;44:329-333.
11. Balm M, Hammack J. Leptomeningeal carcinotasis: presenting features and prognostic factors. Arch Neurol 1996;53:626-632.
12. Fishman RA. Cerebrospinal fluid in diseases of the nervous system. Philadelphia: WB Saunders 1992.
13. Bossolasco S, Nilsson A, Milito A, et al. Soluble CD23 in cerebrospinal fluid: a marker of AIDS related non-Hodgkin's lymphoma in the brain. AIDS 2001;15:1109-1113.
14. Murare S, Saio M, Takenaka K, et al. Increased levels of CSF soluble CD27 in patients with primary central nervous system lymphoma. Cancer Lett 1998;13:2181-2186.
15. De Luca A, Antinori A, Cingolani A, et al. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol 1995; 90:844-849.
16. Galen RS, Gambino SR. Beyond normality: the predictive value and efficiency of medical diagnoses. New York: John Wiley & Sons 1975.
17. Glass JP, Melamed M, Chernik NL, et al. Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology 1979;29:1369-1375.
18. Watson CW, Hajdu SI. Cytology of primary neoplasm of the central nervous system. Acta Cytol 1977;21:40-47.
19. Sá MJ, Vaz R, Cruz C. Cerebrospinal fluid cytomorphologic findings in 41 intracranial tumors. Arq Neuropsiquiatr 1995;53:218-226.
20. Glantz MJ, Cole BF, Glantz LK, et al. Cerebrospinal fluid cytology in patients wiyh cancer: minimizing false-negative results. Cancer 1998;82:733-739.
21. Kim L, Glantz MJ. Neoplastic meningitis. Curr Treat Options Oncol 2001;2:517-527.
22. Freilich RJ, Krol G, De Angelis LM. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 1995:3851-3857.
23. Sampath P, Weaver CE, Sungarian A, et al. Cerebrospinal fluid (vascular endothelial growth factor) and serologic (Recoverin) tumor markers for malignant glioma. Cancer Control 2004;11:174-180.
24. Hug A, Storch-Hagenlocher B, Haas J, et al. Single-cell PCR analysis of the immunoglobulin heavy-chain CDR3 region for the diagnosis of leptomeningeal involvement of B-cell malignancies using standard cerebrospinal fluid cytospins. J Neurol Sci 2004;219:83-88.
25. Wick M, Fink W, Pfister W, et al. Ferritin in cerebrospinal fluid differentiation between central nervous system haemorrhage and traumatic spinal puncture. J Clin Pathol 1988;41:809
26. Crichton RR. Ferritin: structure, synthesis and function. N Engl J Med 1971;284:1413-1422.
27. Wick M, Huber M, Bayerl B, et al. Ferritin in CSF: characterization and possible origin. In: Felgenhauer K, Holzgraefe M, Prange HW (Eds.). CNS Barriers and moderns CSF diagnosis. Weinheim Verlagsgesellschaft 1993:274-277.
28. Harrison PM, Hoy TG, Macara IG, et al. Ferritin iron uptake and release: structure-function relationships. Biochem J 1974;143:445-451.
29. White GP, Worwood M, Parry D. Ferritin synthesis in normal and leukemic leukocites. Nature 1974;250:584-586.